In silico also known as computer-aided drug design is a process by which the drug is design or discovered by using computational methods. Drug discovery process is carried out to identify new drug molecules that can attach to a specific target. This method of identifying drugs is based on computation and the entire process is considered linear and consecutive. Various factors make in-silico drug discovery method more productive and a wise approach in comparison to earlier drug discovery methods used for the drug development process. In-silico drug design can play a significant role in all stages of drug development 鈥� from the initial lead designing to final stage clinical development.
The global market for In-Silico Drug Discovery was estimated to be worth US$ 1991 million in 2023 and is forecast to a readjusted size of US$ 4413.6 million by 2030 with a CAGR of 11.9% during the forecast period 2024-2030.
The main In-Silico Drug Discovery players include Charles River, Certara USA, Inc., Evotec, etc. The top three In-Silico Drug Discovery players account for approximately 36% of the total global market. In terms of type, Consultancy as a Service is the largest segment, with a share about 41%. And in terms of Application, the largest application is Contract Research Organization, followed by Pharmaceutical Industry.
Report Scope
This report aims to provide a comprehensive presentation of the global market for In-Silico Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding In-Silico Drug Discovery.
The In-Silico Drug Discovery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In-Silico Drug Discovery market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In-Silico Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
麻豆原创 Segmentation
By Company
Charles River
Certara USA, Inc.
Evotec
Dassault System (Biovia)
Albany Molecular Research Inc. (AMRI)
Selvita
Schr枚dinger, Inc.
GVK BIO
OpenEye Scientific Software
Chemical Computing Group (CCG)
Segment by Type
Software as a Service (Cloud)
Consultancy as a Service
Software
Segment by Application
Contract Research Organization
Pharmaceutical Industry
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of In-Silico Drug Discovery in global and regional level.
Chapter 3: Detailed analysis of In-Silico Drug Discovery company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, In-Silico Drug Discovery revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 In-Silico Drug Discovery Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global In-Silico Drug Discovery 麻豆原创 Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Software as a Service (Cloud)
1.2.3 Consultancy as a Service
1.2.4 Software
1.3 麻豆原创 by Application
1.3.1 Global In-Silico Drug Discovery 麻豆原创 Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Contract Research Organization
1.3.3 Pharmaceutical Industry
1.3.4 Academic and Research Institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global In-Silico Drug Discovery 麻豆原创 Size Estimates and Forecasts
2.2 In-Silico Drug Discovery 麻豆原创 Size by Region: 2023 Versus 2030
2.2.1 Global In-Silico Drug Discovery Revenue by Region: 2019-2024
2.2.2 Global In-Silico Drug Discovery Revenue Forecast by Region (2025-2030)
2.2.3 Global In-Silico Drug Discovery Revenue 麻豆原创 Share by Region (2019-2030)
3 Global In-Silico Drug Discovery by Company
3.1 Global In-Silico Drug Discovery Revenue by Company (2019-2024)
3.2 Global In-Silico Drug Discovery Revenue Share by Company (2019-2024)
3.3 Competitive Landscape
3.3.1 Key In-Silico Drug Discovery Companies around the World: Ranking by Revenue
3.3.2 Global In-Silico Drug Discovery 麻豆原创 Concentration Ratio (CR5 and HHI) & (2019-2024)
3.3.3 Global In-Silico Drug Discovery 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global In-Silico Drug Discovery Companies Headquarters & Product Type
3.4.1 In-Silico Drug Discovery Companies Headquarters
3.4.2 Global In-Silico Drug Discovery Companies Product & Service
3.4.3 Date of International Companies Enter into In-Silico Drug Discovery 麻豆原创
3.5 Global In-Silico Drug Discovery Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Charles River
4.1.1 Charles River Company Information
4.1.2 Charles River Description, Business Overview
4.1.3 Charles River In-Silico Drug Discovery Products Offered
4.1.4 Charles River In-Silico Drug Discovery Revenue and Gross Margin (2019-2024)
4.1.5 Charles River In-Silico Drug Discovery Revenue by Product in 2023
4.1.6 Charles River In-Silico Drug Discovery Revenue by Application in 2023
4.1.7 Charles River In-Silico Drug Discovery Revenue by Geographic Area in 2023
4.1.8 Charles River Recent Developments
4.2 Certara USA, Inc.
4.2.1 Certara USA, Inc. Company Information
4.2.2 Certara USA, Inc. Description, Business Overview
4.2.3 Certara USA, Inc. In-Silico Drug Discovery Products Offered
4.2.4 Certara USA, Inc. In-Silico Drug Discovery Revenue and Gross Margin (2019-2024)
4.2.5 Certara USA, Inc. In-Silico Drug Discovery Revenue by Product in 2023
4.2.6 Certara USA, Inc. In-Silico Drug Discovery Revenue by Application in 2023
4.2.7 Certara USA, Inc. In-Silico Drug Discovery Revenue by Geographic Area in 2023
4.2.8 Certara USA, Inc. Recent Developments
4.3 Evotec
4.3.1 Evotec Company Information
4.3.2 Evotec Description, Business Overview
4.3.3 Evotec In-Silico Drug Discovery Products Offered
4.3.4 Evotec In-Silico Drug Discovery Revenue and Gross Margin (2019-2024)
4.3.5 Evotec In-Silico Drug Discovery Revenue by Product in 2023
4.3.6 Evotec In-Silico Drug Discovery Revenue by Application in 2023
4.3.7 Evotec In-Silico Drug Discovery Revenue by Geographic Area in 2023
4.3.8 Evotec Recent Developments
4.4 Dassault System (Biovia)
4.4.1 Dassault System (Biovia) Company Information
4.4.2 Dassault System (Biovia) Description, Business Overview
4.4.3 Dassault System (Biovia) In-Silico Drug Discovery Products Offered
4.4.4 Dassault System (Biovia) In-Silico Drug Discovery Revenue and Gross Margin (2019-2024)
4.4.5 Dassault System (Biovia) In-Silico Drug Discovery Revenue by Product in 2023
4.4.6 Dassault System (Biovia) In-Silico Drug Discovery Revenue by Application in 2023
4.4.7 Dassault System (Biovia) In-Silico Drug Discovery Revenue by Geographic Area in 2023
4.4.8 Dassault System (Biovia) Recent Developments
4.5 Albany Molecular Research Inc. (AMRI)
4.5.1 Albany Molecular Research Inc. (AMRI) Company Information
4.5.2 Albany Molecular Research Inc. (AMRI) Description, Business Overview
4.5.3 Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Products Offered
4.5.4 Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Revenue and Gross Margin (2019-2024)
4.5.5 Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Revenue by Product in 2023
4.5.6 Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Revenue by Application in 2023
4.5.7 Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Revenue by Geographic Area in 2023
4.5.8 Albany Molecular Research Inc. (AMRI) Recent Developments
4.6 Selvita
4.6.1 Selvita Company Information
4.6.2 Selvita Description, Business Overview
4.6.3 Selvita In-Silico Drug Discovery Products Offered
4.6.4 Selvita In-Silico Drug Discovery Revenue and Gross Margin (2019-2024)
4.6.5 Selvita In-Silico Drug Discovery Revenue by Product in 2023
4.6.6 Selvita In-Silico Drug Discovery Revenue by Application in 2023
4.6.7 Selvita In-Silico Drug Discovery Revenue by Geographic Area in 2023
4.6.8 Selvita Recent Development
4.7 Schr枚dinger, Inc.
4.7.1 Schr枚dinger, Inc. Company Information
4.7.2 Schr枚dinger, Inc. Description, Business Overview
4.7.3 Schr枚dinger, Inc. In-Silico Drug Discovery Products Offered
4.7.4 Schr枚dinger, Inc. In-Silico Drug Discovery Revenue and Gross Margin (2019-2024)
4.7.5 Schr枚dinger, Inc. In-Silico Drug Discovery Revenue by Product in 2023
4.7.6 Schr枚dinger, Inc. In-Silico Drug Discovery Revenue by Application in 2023
4.7.7 Schr枚dinger, Inc. In-Silico Drug Discovery Revenue by Geographic Area in 2023
4.7.8 Schr枚dinger, Inc. Recent Development
4.8 GVK BIO
4.8.1 GVK BIO Company Information
4.8.2 GVK BIO Description, Business Overview
4.8.3 GVK BIO In-Silico Drug Discovery Products Offered
4.8.4 GVK BIO In-Silico Drug Discovery Revenue and Gross Margin (2019-2024)
4.8.5 GVK BIO In-Silico Drug Discovery Revenue by Product in 2023
4.8.6 GVK BIO In-Silico Drug Discovery Revenue by Application in 2023
4.8.7 GVK BIO In-Silico Drug Discovery Revenue by Geographic Area in 2023
4.8.8 GVK BIO Recent Development
4.9 OpenEye Scientific Software
4.9.1 OpenEye Scientific Software Company Information
4.9.2 OpenEye Scientific Software Description, Business Overview
4.9.3 OpenEye Scientific Software In-Silico Drug Discovery Products Offered
4.9.4 OpenEye Scientific Software In-Silico Drug Discovery Revenue and Gross Margin (2019-2024)
4.9.5 OpenEye Scientific Software In-Silico Drug Discovery Revenue by Product in 2023
4.9.6 OpenEye Scientific Software In-Silico Drug Discovery Revenue by Application in 2023
4.9.7 OpenEye Scientific Software In-Silico Drug Discovery Revenue by Geographic Area in 2023
4.9.8 OpenEye Scientific Software Recent Development
4.10 Chemical Computing Group (CCG)
4.10.1 Chemical Computing Group (CCG) Company Information
4.10.2 Chemical Computing Group (CCG) Description, Business Overview
4.10.3 Chemical Computing Group (CCG) In-Silico Drug Discovery Products Offered
4.10.4 Chemical Computing Group (CCG) In-Silico Drug Discovery Revenue and Gross Margin (2019-2024)
4.10.5 Chemical Computing Group (CCG) In-Silico Drug Discovery Revenue by Product in 2023
4.10.6 Chemical Computing Group (CCG) In-Silico Drug Discovery Revenue by Application in 2023
4.10.7 Chemical Computing Group (CCG) In-Silico Drug Discovery Revenue by Geographic Area in 2023
4.10.8 Chemical Computing Group (CCG) Recent Development
5 Breakdown Data by Type
5.1 Global In-Silico Drug Discovery Revenue by Type (2019-2024)
5.2 Global In-Silico Drug Discovery Revenue Forecast by Type (2025-2030)
5.3 In-Silico Drug Discovery Revenue 麻豆原创 Share by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global In-Silico Drug Discovery Revenue by Application (2019-2024)
6.2 Global In-Silico Drug Discovery Revenue Forecast by Application (2025-2030)
6.3 In-Silico Drug Discovery Revenue 麻豆原创 Share by Application (2019-2030)
7 North America
7.1 North America In-Silico Drug Discovery 麻豆原创 Size YoY Growth 2019-2030
7.2 North America In-Silico Drug Discovery 麻豆原创 Facts & Figures by Country (2019-2030)
7.3 North America In-Silico Drug Discovery Revenue by Type (2019-2024)
7.4 North America In-Silico Drug Discovery Revenue by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific In-Silico Drug Discovery 麻豆原创 Size YoY Growth 2019-2030
8.2 Asia-Pacific In-Silico Drug Discovery 麻豆原创 Facts & Figures by Region (2019-2030)
8.3 Asia-Pacific In-Silico Drug Discovery Revenue by Type (2019-2024)
8.4 Asia-Pacific In-Silico Drug Discovery Revenue by Application (2019-2024)
9 Europe
9.1 Europe In-Silico Drug Discovery 麻豆原创 Size YoY Growth 2019-2030
9.2 Europe In-Silico Drug Discovery 麻豆原创 Facts & Figures by Country (2019-2030)
9.3 Europe In-Silico Drug Discovery Revenue by Type (2019-2024)
9.4 Europe In-Silico Drug Discovery Revenue by Application (2019-2024)
10 Latin America
10.1 Latin America In-Silico Drug Discovery 麻豆原创 Size YoY Growth 2019-2030
10.2 Latin America In-Silico Drug Discovery 麻豆原创 Facts & Figures by Country (2019-2030)
10.3 Latin America In-Silico Drug Discovery Revenue by Type (2019-2024)
10.4 Latin America In-Silico Drug Discovery Revenue by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa In-Silico Drug Discovery 麻豆原创 Size YoY Growth 2019-2030
11.2 Middle East and Africa In-Silico Drug Discovery 麻豆原创 Facts & Figures by Country (2019-2030)
11.3 Middle East and Africa In-Silico Drug Discovery Revenue by Type (2019-2024)
11.4 Middle East and Africa In-Silico Drug Discovery Revenue by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 In-Silico Drug Discovery Supply Chain Analysis
12.2 In-Silico Drug Discovery Key Raw Materials and Upstream Suppliers
12.3 In-Silico Drug Discovery Clients Analysis
12.4 In-Silico Drug Discovery Sales Channel and Sales Model Analysis
12.4.1 In-Silico Drug Discovery Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 In-Silico Drug Discovery Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 In-Silico Drug Discovery Distributors
13 麻豆原创 Dynamics
13.1 In-Silico Drug Discovery Industry Trends
13.2 In-Silico Drug Discovery 麻豆原创 Drivers
13.3 In-Silico Drug Discovery 麻豆原创 Challenges
13.4 In-Silico Drug Discovery 麻豆原创 Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Charles River
Certara USA, Inc.
Evotec
Dassault System (Biovia)
Albany Molecular Research Inc. (AMRI)
Selvita
Schr枚dinger, Inc.
GVK BIO
OpenEye Scientific Software
Chemical Computing Group (CCG)
听
听
*If Applicable.
